Your browser doesn't support javascript.
loading
Capturing Hyperprogressive Disease with Immune-Checkpoint Inhibitors Using RECIST 1.1 Criteria.
Matos, Ignacio; Martin-Liberal, Juan; García-Ruiz, Alonso; Hierro, Cinta; Ochoa de Olza, Maria; Viaplana, Cristina; Azaro, Analia; Vieito, Maria; Braña, Irene; Mur, Gemma; Ros, Javier; Mateos, Jose; Villacampa, Guillermo; Berché, Roger; Oliveira, Mafalda; Alsina, Maria; Elez, Elena; Oaknin, Ana; Muñoz-Couselo, Eva; Carles, Joan; Felip, Enriqueta; Rodón, Jordi; Tabernero, Josep; Dienstmann, Rodrigo; Perez-Lopez, Raquel; Garralda, Elena.
Afiliación
  • Matos I; Department of Medical Oncology, Vall d'Hebron University Hospital. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. egarralda@vhio.net imatos@vhio.net.
  • Martin-Liberal J; Deparment of Medicine. Universidad Autónoma de Barcelona, Spain.
  • García-Ruiz A; Department of Medical Oncology, Vall d'Hebron University Hospital. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Hierro C; Radiomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Ochoa de Olza M; Department of Medical Oncology, Vall d'Hebron University Hospital. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Viaplana C; Department of Medical Oncology, Vall d'Hebron University Hospital. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Azaro A; Oncology Data Science (OdysSey) Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Vieito M; Department of Medical Oncology, Vall d'Hebron University Hospital. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Braña I; Department of Medical Oncology, Vall d'Hebron University Hospital. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Mur G; Department of Medical Oncology, Vall d'Hebron University Hospital. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Ros J; Clinical trials office, Vall d'Hebron Institute Oncology (VHIO), Barcelona, Spain.
  • Mateos J; Department of Medical Oncology, Vall d'Hebron University Hospital. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Villacampa G; Radiology Department. Imagen ensayos clínicos at Hospital Quiron Barcelona, Spain.
  • Berché R; Oncology Data Science (OdysSey) Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Oliveira M; Oncology Data Science (OdysSey) Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Alsina M; Department of Medical Oncology, Vall d'Hebron University Hospital. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Elez E; Department of Medical Oncology, Vall d'Hebron University Hospital. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Oaknin A; Department of Medical Oncology, Vall d'Hebron University Hospital. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Muñoz-Couselo E; Department of Medical Oncology, Vall d'Hebron University Hospital. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Carles J; Department of Medical Oncology, Vall d'Hebron University Hospital. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Felip E; Department of Medical Oncology, Vall d'Hebron University Hospital. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Rodón J; Department of Medical Oncology, Vall d'Hebron University Hospital. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Tabernero J; Deparment of Medicine. Universidad Autónoma de Barcelona, Spain.
  • Dienstmann R; Department of Medical Oncology, Vall d'Hebron University Hospital. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Perez-Lopez R; Department of Medical Oncology, Vall d'Hebron University Hospital. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Garralda E; Deparment of Medicine. Universidad Autónoma de Barcelona, Spain.
Clin Cancer Res ; 26(8): 1846-1855, 2020 04 15.
Article en En | MEDLINE | ID: mdl-31757877
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carga Tumoral / Terapia Molecular Dirigida / Criterios de Evaluación de Respuesta en Tumores Sólidos / Inhibidores de Puntos de Control Inmunológico / Inmunoterapia / Neoplasias Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carga Tumoral / Terapia Molecular Dirigida / Criterios de Evaluación de Respuesta en Tumores Sólidos / Inhibidores de Puntos de Control Inmunológico / Inmunoterapia / Neoplasias Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article